Rajeev Dadoo
Signal active
Partner
Bio
Rajeev joined SR One in 2004 and is an alum of the Kauffman Fellows Program. Rajeev has been involved with SR Ones investments in Cydex, Hypnion, Predix Pharmaceuticals, Rib-X Pharmaceuticals, Octoplus, Trigen, Nucleonics, and Pinnacle Pharmaceuticals. In addition to his role at SR One, Rajeev spent time with the Competitive Excellence group within GSK working on company-wide strategic projects for GSKs Corporate Executive Team.
Location
San Francisco, California, United States, North America
Social
Primary Organization
SR One
Founded
1985
Investment
190
Lead investment
60
Exits
58
Employees
1-10
Industry
Financial Services, Venture Capital, Finance, Health Care
Jobs history
2
Board of Directors
2021 - Current
Tranquis Therapeutics
Board Member
2020 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Rajeev Dadoo is the Partner at SR One, based in United States, North America. With a background in Financial Services, Rajeev Dadoo has a rich history of leadership and innovation. Rajeev Dadoo studied Ph.D Chemistry @ Stanford University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
6
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Aug 31, 2021 | - | Series D - ARS Pharmaceuticals | SR One | 55.0M |
| Jun 14, 2022 | Dren Bio | Series B - Dren Bio | SR One | 65.0M |
| Sep 06, 2023 | Nimbus Therapeutics | Private Equity Round - Nimbus Therapeutics | SR One | 210.0M |
| Jul 17, 2024 | - | Series A - Renalys Pharma | SR One | 38.0M |
SR OneExits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.